 Kumar Rajan
Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| African Americans | 19 | 2021 | 780 | 4.930 |
Why?
| | Apolipoprotein E4 | 9 | 2021 | 208 | 3.860 |
Why?
| | Cognition Disorders | 13 | 2018 | 1064 | 2.900 |
Why?
| | Alzheimer Disease | 13 | 2021 | 1751 | 2.810 |
Why?
| | Cognition | 18 | 2022 | 1141 | 2.370 |
Why?
| | Activities of Daily Living | 8 | 2018 | 472 | 1.920 |
Why?
| | Aged | 54 | 2022 | 10156 | 1.890 |
Why?
| | Longitudinal Studies | 22 | 2022 | 1432 | 1.880 |
Why?
| | Population Surveillance | 3 | 2021 | 129 | 1.700 |
Why?
| | Apolipoproteins E | 4 | 2021 | 202 | 1.700 |
Why?
| | Female | 63 | 2021 | 18107 | 1.590 |
Why?
| | Male | 55 | 2021 | 17552 | 1.570 |
Why?
| | Aging | 8 | 2021 | 1551 | 1.500 |
Why?
| | Stroke | 4 | 2016 | 345 | 1.480 |
Why?
| | Aged, 80 and over | 28 | 2021 | 5172 | 1.400 |
Why?
| | Humans | 70 | 2022 | 30741 | 1.320 |
Why?
| | Mortality | 4 | 2021 | 97 | 1.270 |
Why?
| | Dementia | 7 | 2021 | 509 | 1.260 |
Why?
| | Risk Factors | 18 | 2021 | 2611 | 1.220 |
Why?
| | Chicago | 17 | 2021 | 945 | 1.190 |
Why?
| | Disease Progression | 9 | 2019 | 851 | 1.180 |
Why?
| | Genotype | 6 | 2018 | 447 | 1.160 |
Why?
| | Disability Evaluation | 4 | 2014 | 330 | 1.050 |
Why?
| | Exercise | 7 | 2021 | 431 | 0.960 |
Why?
| | Antihypertensive Agents | 2 | 2021 | 91 | 0.890 |
Why?
| | Neurofilament Proteins | 1 | 2020 | 6 | 0.880 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2020 | 37 | 0.870 |
Why?
| | Blood Pressure | 2 | 2021 | 250 | 0.860 |
Why?
| | Depression | 3 | 2014 | 502 | 0.850 |
Why?
| | Membrane Proteins | 1 | 2021 | 211 | 0.810 |
Why?
| | tau Proteins | 1 | 2020 | 165 | 0.800 |
Why?
| | European Continental Ancestry Group | 3 | 2018 | 66 | 0.790 |
Why?
| | Geriatric Assessment | 4 | 2021 | 230 | 0.770 |
Why?
| | Incidence | 9 | 2020 | 827 | 0.710 |
Why?
| | Alleles | 6 | 2021 | 230 | 0.700 |
Why?
| | Neuropsychological Tests | 11 | 2018 | 1278 | 0.690 |
Why?
| | Art | 1 | 2016 | 3 | 0.670 |
Why?
| | Music | 1 | 2016 | 24 | 0.650 |
Why?
| | Prospective Studies | 7 | 2018 | 1891 | 0.640 |
Why?
| | Diabetes Complications | 1 | 2016 | 71 | 0.630 |
Why?
| | African Continental Ancestry Group | 2 | 2015 | 30 | 0.630 |
Why?
| | Models, Statistical | 2 | 2021 | 146 | 0.630 |
Why?
| | Time Factors | 8 | 2021 | 1911 | 0.610 |
Why?
| | Obesity | 6 | 2014 | 322 | 0.580 |
Why?
| | Genetic Predisposition to Disease | 5 | 2021 | 473 | 0.570 |
Why?
| | Body Mass Index | 6 | 2018 | 438 | 0.560 |
Why?
| | Gene-Environment Interaction | 1 | 2014 | 19 | 0.560 |
Why?
| | Mobility Limitation | 1 | 2015 | 99 | 0.550 |
Why?
| | Depressive Disorder | 1 | 2015 | 213 | 0.540 |
Why?
| | Memantine | 1 | 2014 | 12 | 0.540 |
Why?
| | United States | 9 | 2021 | 2467 | 0.540 |
Why?
| | Vitamin E | 1 | 2014 | 43 | 0.540 |
Why?
| | Dopamine Agents | 1 | 2014 | 41 | 0.540 |
Why?
| | Cohort Studies | 11 | 2021 | 1959 | 0.530 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2016 | 222 | 0.520 |
Why?
| | Antioxidants | 1 | 2014 | 70 | 0.520 |
Why?
| | Follow-Up Studies | 9 | 2018 | 2046 | 0.520 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2021 | 331 | 0.520 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 391 | 0.510 |
Why?
| | Health Status Disparities | 1 | 2013 | 68 | 0.500 |
Why?
| | Memory, Episodic | 3 | 2018 | 105 | 0.490 |
Why?
| | Diagnosis | 1 | 2011 | 24 | 0.480 |
Why?
| | Genome-Wide Association Study | 4 | 2018 | 308 | 0.470 |
Why?
| | Medical Informatics | 1 | 2011 | 11 | 0.470 |
Why?
| | Area Under Curve | 1 | 2011 | 78 | 0.470 |
Why?
| | Motor Activity | 1 | 2015 | 395 | 0.470 |
Why?
| | Refusal to Participate | 1 | 2010 | 2 | 0.440 |
Why?
| | Linear Models | 3 | 2016 | 277 | 0.440 |
Why?
| | Disabled Persons | 1 | 2012 | 110 | 0.430 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 631 | 0.380 |
Why?
| | Age of Onset | 3 | 2014 | 115 | 0.380 |
Why?
| | Genetic Loci | 3 | 2018 | 68 | 0.370 |
Why?
| | Prevalence | 2 | 2021 | 546 | 0.360 |
Why?
| | Postmenopause | 7 | 2006 | 67 | 0.350 |
Why?
| | Memory Disorders | 2 | 2018 | 180 | 0.320 |
Why?
| | Middle Aged | 20 | 2019 | 11256 | 0.310 |
Why?
| | Hypoglycemic Agents | 2 | 2016 | 76 | 0.280 |
Why?
| | Regression Analysis | 4 | 2011 | 323 | 0.240 |
Why?
| | Independent Living | 2 | 2022 | 230 | 0.240 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 9 | 0.230 |
Why?
| | Blood-Brain Barrier | 1 | 2021 | 45 | 0.220 |
Why?
| | Cost of Illness | 1 | 2021 | 65 | 0.220 |
Why?
| | Noise | 1 | 2020 | 32 | 0.220 |
Why?
| | Early Diagnosis | 1 | 2020 | 76 | 0.210 |
Why?
| | Mental Status Schedule | 2 | 2018 | 121 | 0.210 |
Why?
| | Neuroimaging | 1 | 2020 | 122 | 0.200 |
Why?
| | Confidence Intervals | 2 | 2017 | 105 | 0.190 |
Why?
| | Phototherapy | 1 | 2019 | 39 | 0.190 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 14 | 0.190 |
Why?
| | Residence Characteristics | 1 | 2020 | 222 | 0.190 |
Why?
| | Social Networking | 1 | 2018 | 10 | 0.190 |
Why?
| | Cerebral Cortex | 1 | 2020 | 203 | 0.190 |
Why?
| | Behavioral Symptoms | 1 | 2018 | 17 | 0.180 |
Why?
| | Psychotropic Drugs | 1 | 2018 | 29 | 0.180 |
Why?
| | Interviews as Topic | 2 | 2016 | 148 | 0.180 |
Why?
| | Nursing Homes | 1 | 2018 | 42 | 0.180 |
Why?
| | Hippocampus | 1 | 2020 | 286 | 0.180 |
Why?
| | Odds Ratio | 2 | 2017 | 328 | 0.180 |
Why?
| | Defecation | 1 | 2017 | 4 | 0.170 |
Why?
| | Low Back Pain | 1 | 2019 | 125 | 0.170 |
Why?
| | Socioeconomic Factors | 3 | 2014 | 362 | 0.170 |
Why?
| | Starch | 1 | 2017 | 7 | 0.170 |
Why?
| | Prebiotics | 1 | 2017 | 9 | 0.170 |
Why?
| | Social Environment | 1 | 2018 | 93 | 0.170 |
Why?
| | Microspheres | 1 | 2017 | 30 | 0.170 |
Why?
| | Dietary Fiber | 1 | 2017 | 22 | 0.170 |
Why?
| | Pain Management | 1 | 2019 | 140 | 0.170 |
Why?
| | Genetic Association Studies | 1 | 2017 | 90 | 0.170 |
Why?
| | Mucormycosis | 1 | 2017 | 7 | 0.170 |
Why?
| | Frozen Sections | 1 | 2017 | 11 | 0.170 |
Why?
| | Aspergillosis | 1 | 2017 | 14 | 0.170 |
Why?
| | Birth Order | 1 | 2016 | 2 | 0.170 |
Why?
| | Parity | 1 | 2016 | 5 | 0.170 |
Why?
| | Reproductive Behavior | 1 | 2016 | 4 | 0.170 |
Why?
| | Reproduction | 1 | 2016 | 10 | 0.170 |
Why?
| | Terrorism | 1 | 2016 | 15 | 0.160 |
Why?
| | Quantitative Trait Loci | 1 | 2016 | 65 | 0.160 |
Why?
| | Iodide Peroxidase | 1 | 2018 | 142 | 0.160 |
Why?
| | Reading | 1 | 2016 | 41 | 0.160 |
Why?
| | Inflammation | 1 | 2018 | 345 | 0.160 |
Why?
| | Brief Psychiatric Rating Scale | 1 | 2015 | 8 | 0.150 |
Why?
| | Overweight | 2 | 2014 | 64 | 0.150 |
Why?
| | Carbohydrate Metabolism | 1 | 2015 | 8 | 0.150 |
Why?
| | Self Report | 1 | 2016 | 217 | 0.150 |
Why?
| | Carbohydrates | 1 | 2015 | 12 | 0.150 |
Why?
| | Chromatography, Gas | 1 | 2015 | 12 | 0.150 |
Why?
| | Urinalysis | 1 | 2015 | 10 | 0.150 |
Why?
| | Clinical Competence | 2 | 2015 | 268 | 0.150 |
Why?
| | Models, Genetic | 1 | 2015 | 44 | 0.150 |
Why?
| | Emergency Medicine | 1 | 2015 | 36 | 0.140 |
Why?
| | Anxiety Disorders | 1 | 2016 | 175 | 0.140 |
Why?
| | Educational Measurement | 1 | 2015 | 65 | 0.140 |
Why?
| | Insulin | 2 | 2014 | 115 | 0.140 |
Why?
| | Adipose Tissue | 3 | 2005 | 95 | 0.140 |
Why?
| | Blood Glucose | 2 | 2014 | 136 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 1244 | 0.140 |
Why?
| | Demography | 1 | 2014 | 82 | 0.140 |
Why?
| | Rhinitis | 1 | 2017 | 161 | 0.140 |
Why?
| | Intelligence Tests | 1 | 2014 | 18 | 0.140 |
Why?
| | Interview, Psychological | 1 | 2014 | 45 | 0.140 |
Why?
| | Hypoglycemia | 1 | 2014 | 18 | 0.140 |
Why?
| | Cats | 1 | 2014 | 82 | 0.140 |
Why?
| | Asian Americans | 1 | 2014 | 53 | 0.130 |
Why?
| | Ultrasonography | 1 | 2015 | 204 | 0.130 |
Why?
| | Medicare | 1 | 2014 | 103 | 0.130 |
Why?
| | Life Style | 2 | 2014 | 208 | 0.130 |
Why?
| | Sinusitis | 1 | 2017 | 189 | 0.130 |
Why?
| | Hospitalization | 2 | 2014 | 344 | 0.130 |
Why?
| | Models, Psychological | 1 | 2014 | 88 | 0.130 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 204 | 0.130 |
Why?
| | White Matter | 1 | 2015 | 124 | 0.130 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 385 | 0.130 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 233 | 0.120 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 140 | 0.120 |
Why?
| | Adenoma | 1 | 2013 | 57 | 0.120 |
Why?
| | Adult | 9 | 2019 | 9760 | 0.120 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2014 | 386 | 0.120 |
Why?
| | Colonoscopy | 1 | 2013 | 86 | 0.120 |
Why?
| | Urban Population | 1 | 2013 | 158 | 0.120 |
Why?
| | Databases, Factual | 1 | 2014 | 372 | 0.120 |
Why?
| | Social Support | 1 | 2014 | 217 | 0.120 |
Why?
| | Health Status | 1 | 2014 | 252 | 0.120 |
Why?
| | Multicenter Studies as Topic | 1 | 2011 | 69 | 0.120 |
Why?
| | ROC Curve | 1 | 2011 | 155 | 0.110 |
Why?
| | Femoracetabular Impingement | 1 | 2015 | 143 | 0.110 |
Why?
| | Vascular Diseases | 1 | 2011 | 58 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2013 | 121 | 0.110 |
Why?
| | Gait | 1 | 2015 | 388 | 0.110 |
Why?
| | Elder Abuse | 1 | 2011 | 30 | 0.110 |
Why?
| | Stress, Psychological | 1 | 2013 | 278 | 0.110 |
Why?
| | Breast Neoplasms | 3 | 2004 | 440 | 0.110 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 141 | 0.110 |
Why?
| | Testosterone | 3 | 2004 | 36 | 0.100 |
Why?
| | Computer Simulation | 1 | 2010 | 246 | 0.100 |
Why?
| | Algorithms | 1 | 2010 | 421 | 0.090 |
Why?
| | Common Cold | 1 | 2006 | 1 | 0.080 |
Why?
| | Pilot Projects | 2 | 2019 | 440 | 0.080 |
Why?
| | Young Adult | 3 | 2018 | 2249 | 0.080 |
Why?
| | Phenotype | 2 | 2016 | 368 | 0.070 |
Why?
| | Parent-Child Relations | 1 | 2005 | 35 | 0.070 |
Why?
| | Peptide Hormones | 1 | 2004 | 3 | 0.070 |
Why?
| | Diet, Reducing | 1 | 2004 | 12 | 0.070 |
Why?
| | Observer Variation | 2 | 2015 | 146 | 0.070 |
Why?
| | Smoking Cessation | 1 | 2005 | 51 | 0.070 |
Why?
| | Androgens | 1 | 2004 | 8 | 0.070 |
Why?
| | Sulfotransferases | 1 | 2004 | 7 | 0.070 |
Why?
| | Glucuronosyltransferase | 1 | 2004 | 7 | 0.070 |
Why?
| | Attitude to Health | 1 | 2005 | 116 | 0.070 |
Why?
| | Estrogens | 1 | 2004 | 36 | 0.070 |
Why?
| | Parents | 1 | 2005 | 102 | 0.070 |
Why?
| | Animals | 1 | 2014 | 5221 | 0.070 |
Why?
| | Psychomotor Performance | 2 | 2018 | 245 | 0.070 |
Why?
| | Gonadal Steroid Hormones | 1 | 2003 | 13 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 594 | 0.070 |
Why?
| | Leisure Activities | 1 | 2022 | 14 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 957 | 0.060 |
Why?
| | Diet Surveys | 1 | 2021 | 24 | 0.060 |
Why?
| | Washington | 3 | 2006 | 7 | 0.060 |
Why?
| | Atrophy | 1 | 2021 | 107 | 0.060 |
Why?
| | Survivors | 2 | 2016 | 64 | 0.060 |
Why?
| | Logistic Models | 2 | 2013 | 479 | 0.050 |
Why?
| | Autopsy | 1 | 2021 | 334 | 0.050 |
Why?
| | Diet, Mediterranean | 1 | 2020 | 53 | 0.050 |
Why?
| | Smoking | 2 | 2015 | 197 | 0.050 |
Why?
| | Alcohol Drinking | 1 | 2020 | 82 | 0.050 |
Why?
| | Pain Threshold | 1 | 2019 | 25 | 0.050 |
Why?
| | Mendelian Randomization Analysis | 1 | 2018 | 5 | 0.050 |
Why?
| | Brain | 2 | 2021 | 1574 | 0.050 |
Why?
| | Hypertension | 1 | 2021 | 272 | 0.050 |
Why?
| | Military Personnel | 1 | 2019 | 40 | 0.050 |
Why?
| | Neurotic Disorders | 1 | 2018 | 19 | 0.050 |
Why?
| | Child | 2 | 2018 | 1547 | 0.050 |
Why?
| | Threonine | 1 | 2018 | 15 | 0.050 |
Why?
| | Alanine | 1 | 2018 | 19 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2018 | 41 | 0.050 |
Why?
| | Community Health Planning | 1 | 2018 | 21 | 0.050 |
Why?
| | Gene Frequency | 1 | 2018 | 86 | 0.050 |
Why?
| | Awareness | 1 | 2018 | 51 | 0.050 |
Why?
| | Schizophrenia | 1 | 2018 | 80 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2018 | 133 | 0.050 |
Why?
| | Veterans | 1 | 2019 | 70 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2018 | 136 | 0.040 |
Why?
| | Chronic Pain | 1 | 2019 | 98 | 0.040 |
Why?
| | Fermentation | 1 | 2017 | 13 | 0.040 |
Why?
| | Constipation | 1 | 2017 | 27 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2017 | 23 | 0.040 |
Why?
| | Mucor | 1 | 2017 | 4 | 0.040 |
Why?
| | Aspergillus | 1 | 2017 | 7 | 0.040 |
Why?
| | Nasal Surgical Procedures | 1 | 2017 | 8 | 0.040 |
Why?
| | Educational Status | 1 | 2018 | 285 | 0.040 |
Why?
| | Feces | 1 | 2017 | 82 | 0.040 |
Why?
| | Maternal Age | 1 | 2016 | 18 | 0.040 |
Why?
| | Oncogene Protein v-akt | 1 | 2016 | 14 | 0.040 |
Why?
| | Fertility | 1 | 2016 | 16 | 0.040 |
Why?
| | Russia | 1 | 2016 | 4 | 0.040 |
Why?
| | Jews | 1 | 2016 | 5 | 0.040 |
Why?
| | Israel | 1 | 2016 | 19 | 0.040 |
Why?
| | Arabs | 1 | 2016 | 6 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2017 | 51 | 0.040 |
Why?
| | Emigration and Immigration | 1 | 2016 | 17 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2017 | 56 | 0.040 |
Why?
| | Sex Factors | 1 | 2018 | 535 | 0.040 |
Why?
| | Nose | 1 | 2017 | 34 | 0.040 |
Why?
| | Liver | 1 | 2018 | 216 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 51 | 0.040 |
Why?
| | Adolescent | 2 | 2018 | 2627 | 0.040 |
Why?
| | Acute Disease | 1 | 2017 | 272 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2018 | 694 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2017 | 550 | 0.040 |
Why?
| | Diet | 1 | 2017 | 188 | 0.040 |
Why?
| | Ankle | 1 | 2015 | 18 | 0.040 |
Why?
| | Gallbladder | 1 | 2015 | 5 | 0.040 |
Why?
| | Anatomic Landmarks | 1 | 2015 | 8 | 0.040 |
Why?
| | Age Factors | 1 | 2018 | 941 | 0.040 |
Why?
| | Chromosomes, Human | 1 | 2015 | 7 | 0.040 |
Why?
| | Sleep | 1 | 2019 | 340 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2019 | 296 | 0.040 |
Why?
| | Knee | 1 | 2015 | 46 | 0.040 |
Why?
| | Pregnancy | 1 | 2016 | 452 | 0.040 |
Why?
| | Endoscopy | 1 | 2017 | 177 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2015 | 30 | 0.040 |
Why?
| | Hip | 1 | 2015 | 40 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2015 | 43 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2015 | 49 | 0.040 |
Why?
| | Point-of-Care Systems | 1 | 2015 | 29 | 0.040 |
Why?
| | Intestinal Absorption | 1 | 2015 | 40 | 0.040 |
Why?
| | Decision Making | 1 | 2017 | 228 | 0.040 |
Why?
| | Permeability | 1 | 2015 | 142 | 0.040 |
Why?
| | China | 1 | 2014 | 121 | 0.040 |
Why?
| | Kinetics | 1 | 2015 | 278 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2014 | 3456 | 0.030 |
Why?
| | Estrone | 2 | 2004 | 6 | 0.030 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2004 | 15 | 0.030 |
Why?
| | Body Weight | 2 | 2004 | 165 | 0.030 |
Why?
| | Estradiol | 2 | 2004 | 69 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2015 | 126 | 0.030 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 59 | 0.030 |
Why?
| | Radiography | 1 | 2015 | 714 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2013 | 181 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2015 | 712 | 0.030 |
Why?
| | Patient Compliance | 2 | 2005 | 201 | 0.030 |
Why?
| | Critical Illness | 1 | 2014 | 120 | 0.030 |
Why?
| | Medical Record Linkage | 1 | 2011 | 5 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 91 | 0.030 |
Why?
| | Range of Motion, Articular | 1 | 2015 | 697 | 0.030 |
Why?
| | Length of Stay | 1 | 2014 | 371 | 0.030 |
Why?
| | Perception | 1 | 2011 | 86 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2014 | 300 | 0.030 |
Why?
| | Risk | 1 | 2011 | 232 | 0.030 |
Why?
| | Cross Infection | 1 | 2014 | 291 | 0.030 |
Why?
| | Caregivers | 1 | 2011 | 147 | 0.030 |
Why?
| | Memory | 1 | 2011 | 333 | 0.020 |
Why?
| | Parkinson Disease | 1 | 2016 | 1136 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2006 | 16 | 0.020 |
Why?
| | Respiratory Tract Infections | 1 | 2006 | 53 | 0.020 |
Why?
| | Ghrelin | 1 | 2004 | 3 | 0.020 |
Why?
| | Leptin | 1 | 2005 | 25 | 0.020 |
Why?
| | Triglycerides | 1 | 2005 | 48 | 0.020 |
Why?
| | Health Education | 1 | 2005 | 50 | 0.020 |
Why?
| | Body Size | 1 | 2004 | 15 | 0.020 |
Why?
| | Arylsulfotransferase | 1 | 2004 | 1 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2004 | 24 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2005 | 69 | 0.020 |
Why?
| | Body Composition | 1 | 2005 | 77 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2004 | 36 | 0.020 |
Why?
| | Homeostasis | 1 | 2005 | 106 | 0.020 |
Why?
| | Energy Intake | 1 | 2004 | 98 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2004 | 60 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2004 | 96 | 0.020 |
Why?
| | New Mexico | 1 | 2003 | 3 | 0.020 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2003 | 5 | 0.020 |
Why?
| | Anthropometry | 1 | 2003 | 56 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2003 | 80 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2003 | 516 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2004 | 876 | 0.010 |
Why?
|
|
Rajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|